What is the lUCD of choice in women with menorrhagia?
**Core Concept**
The management of menorrhagia in women involves identifying the underlying cause and choosing the most effective treatment option. Levonorgestrel-releasing intrauterine systems (LNG-IUS) are a type of hormone-releasing intrauterine device (IUD) that have been shown to be effective in reducing menstrual blood loss and improving quality of life in women with menorrhagia.
**Why the Correct Answer is Right**
The LNG-IUS works by releasing a small amount of progestin (levonorgestrel) locally into the uterus, which thickens the cervical mucus, thins the uterine lining, and reduces menstrual blood flow. This leads to a significant reduction in menstrual blood loss and a decrease in the frequency of heavy menstrual bleeding. The LNG-IUS is particularly effective in women with menorrhagia due to its ability to reduce menstrual blood loss by up to 90%.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because while oral contraceptives can help regulate menstrual cycles and reduce menstrual blood loss, they are not the first-line treatment for menorrhagia. Oral contraceptives may also have systemic side effects and are not as effective as LNG-IUS in reducing menstrual blood loss.
**Option B:** This option is incorrect because while tranexamic acid can help reduce menstrual blood loss, it is not a long-term solution for menorrhagia. Tranexamic acid is typically used as an adjunctive treatment to other therapies.
**Option C:** This option is incorrect because while hysterectomy may be a treatment option for severe menorrhagia, it is not the first-line treatment and is usually reserved for women who have failed other treatments.
**Clinical Pearl / High-Yield Fact**
The LNG-IUS is a highly effective treatment for menorrhagia, with a success rate of up to 90% in reducing menstrual blood loss. It is also a reversible and non-surgical option that can be used by women of any age, making it a popular choice for women with menorrhagia.
**Correct Answer:** C.